211 related articles for article (PubMed ID: 31468273)
1. Pharmacologic Interventions for Irritability, Aggression, Agitation and Self-Injurious Behavior in Fragile X Syndrome: An Initial Cross-Sectional Analysis.
Eckert EM; Dominick KC; Pedapati EV; Wink LK; Shaffer RC; Andrews H; Choo TH; Chen C; Kaufmann WE; Tartaglia N; Berry-Kravis EM; Erickson CA
J Autism Dev Disord; 2019 Nov; 49(11):4595-4602. PubMed ID: 31468273
[TBL] [Abstract][Full Text] [Related]
2. Brief report: risperidone for severely disturbed behavior and tardive dyskinesia in developmentally disabled adults.
Khan BU
J Autism Dev Disord; 1997 Aug; 27(4):479-89. PubMed ID: 9261670
[No Abstract] [Full Text] [Related]
3. Risperidone Treatment for Irritability in Fragile X Syndrome.
Dominick KC; Wink LK; Pedapati EV; Shaffer R; Sweeney JA; Erickson CA
J Child Adolesc Psychopharmacol; 2018 May; 28(4):274-278. PubMed ID: 29394101
[TBL] [Abstract][Full Text] [Related]
4. Psychopharmacologic management of serious behavioral disturbance in ASD.
Stigler KA
Child Adolesc Psychiatr Clin N Am; 2014 Jan; 23(1):73-82. PubMed ID: 24231168
[TBL] [Abstract][Full Text] [Related]
5. Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study.
Adler BA; Wink LK; Early M; Shaffer R; Minshawi N; McDougle CJ; Erickson CA
Autism; 2015 Jan; 19(1):102-6. PubMed ID: 24571823
[TBL] [Abstract][Full Text] [Related]
6. A prospective open-label study of aripiprazole in fragile X syndrome.
Erickson CA; Stigler KA; Wink LK; Mullett JE; Kohn A; Posey DJ; McDougle CJ
Psychopharmacology (Berl); 2011 Jul; 216(1):85-90. PubMed ID: 21318565
[TBL] [Abstract][Full Text] [Related]
7. Psychotropic Drug Treatment Patterns in Persons with Fragile X Syndrome.
Dominick KC; Andrews HF; Kaufmann WE; Berry-Kravis E; Erickson CA
J Child Adolesc Psychopharmacol; 2021 Dec; 31(10):659-669. PubMed ID: 34818076
[No Abstract] [Full Text] [Related]
8. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.
Marcus RN; Owen R; Kamen L; Manos G; McQuade RD; Carson WH; Aman MG
J Am Acad Child Adolesc Psychiatry; 2009 Nov; 48(11):1110-1119. PubMed ID: 19797985
[TBL] [Abstract][Full Text] [Related]
9. Managing irritability and aggression in autism spectrum disorders in children and adolescents.
Robb AS
Dev Disabil Res Rev; 2010; 16(3):258-64. PubMed ID: 20981764
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy of irritability in pervasive developmental disorders.
Stigler KA; McDougle CJ
Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological management in children and adolescents with pervasive developmental disorder.
Sung M; Fung DS; Cai Y; Ooi YP
Aust N Z J Psychiatry; 2010 May; 44(5):410-28. PubMed ID: 20047454
[TBL] [Abstract][Full Text] [Related]
12. Risperidone for aggression and self-injurious behavior in adults with mental retardation.
Cohen SA; Ihrig K; Lott RS; Kerrick JM
J Autism Dev Disord; 1998 Jun; 28(3):229-33. PubMed ID: 9656134
[TBL] [Abstract][Full Text] [Related]
13. Temporary increases in problem behavior and sleep disruption following decreases in medication: a descriptive analysis of conditional rates.
Rapp JT; Swanson G; Dornbusch K
Behav Modif; 2007 Nov; 31(6):825-46. PubMed ID: 17932238
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis.
Fung LK; Mahajan R; Nozzolillo A; Bernal P; Krasner A; Jo B; Coury D; Whitaker A; Veenstra-Vanderweele J; Hardan AY
Pediatrics; 2016 Feb; 137 Suppl 2():S124-35. PubMed ID: 26908468
[TBL] [Abstract][Full Text] [Related]
15. The Persistence of Self-injurious and Aggressive Behavior in Males with Fragile X Syndrome Over 8 Years: A Longitudinal Study of Prevalence and Predictive Risk Markers.
Crawford H; Karakatsani E; Singla G; Oliver C
J Autism Dev Disord; 2019 Jul; 49(7):2913-2922. PubMed ID: 31020491
[TBL] [Abstract][Full Text] [Related]
16. Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months.
Research Units on Pediatric Psychopharmacology Autism Network
Am J Psychiatry; 2005 Jul; 162(7):1361-9. PubMed ID: 15994720
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis and treatment of problem behavior exhibited by children with fragile X syndrome.
Kurtz PF; Chin MD; Robinson AN; O'Connor JT; Hagopian LP
Res Dev Disabil; 2015; 43-44():150-66. PubMed ID: 26183339
[TBL] [Abstract][Full Text] [Related]
18. Aripiprazole in autism spectrum disorders and fragile X syndrome.
Erickson CA; Stigler KA; Posey DJ; McDougle CJ
Neurotherapeutics; 2010 Jul; 7(3):258-63. PubMed ID: 20643378
[TBL] [Abstract][Full Text] [Related]
19. Problem behaviour in adolescent boys with fragile X syndrome: relative prevalence, frequency and severity.
Hall SS; Barnett RP; Hustyi KM
J Intellect Disabil Res; 2016 Dec; 60(12):1189-1199. PubMed ID: 27730710
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and therapeutic aspects of agitation].
San L
Encephale; 2007 Jun; 33 Pt 3():S375-9. PubMed ID: 19101354
[No Abstract] [Full Text] [Related]
[Next] [New Search]
